Publications
Publications
- E-liquid exposure induces bladder cancer cells to release extracellular vesicles that promote non-malignant urothelial cell transformation.; Scientific reports; Vol 13(1), pp. 142. 2023 Jan 04.
- Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity.; International journal of molecular sciences; Vol 23(6). 2022 Mar 08.
- Prevention of radiation-induced bladder injury: A murine study using captopril.; International journal of radiation oncology, biology, physics. 2022 Jan 15.
- Non-stem bladder cancer cell-derived extracellular vesicles promote cancer stem cell survival in response to chemotherapy.; Stem cell research & therapy; Vol 12(1). 2021 Oct 09.
- Tenascin-C expression in the lymph node pre-metastatic niche in muscle-invasive bladder cancer.; British journal of cancer. 2021 Sep 25.
- Active vitamin D induced gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance.; American journal of physiology. Cell physiology. 2020 Mar 11.
- Bladder cancer extracellular vesicles drive tumorigenesis by inducing the unfolded protein response in endoplasmic reticulum of non-malignant cells.; The Journal of biological chemistry. 2018 Dec 28.
- A Festschrift in Honor of Edward M. Messing, MD, FACS.; Bladder cancer (Amsterdam, Netherlands); Vol 4(Suppl 1). 2018 Oct 03.
- Extracellular Vesicles in Bladder Cancer: Biomarkers and Beyond.; International journal of molecular sciences; Vol 19(9). 2018 Sep 18.
- Characterization of urinary extracellular vesicle proteins in muscle-invasive bladder cancer.; Oncotarget; Vol 8(53). 2017 Oct 31.
- Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer.; Oncotarget. 2016 Mar 10.
- E-selectin ligand-1 controls circulating prostate cancer cell rolling/adhesion and metastasis.; Oncotarget; Vol 5(23). 2014 Dec 15.
- Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression.; The Journal of urology; Vol 192(2). 2014 Aug.
- TR4 nuclear receptor functions as a tumor suppressor for prostate tumorigenesis via modulation of DNA damage/repair system.; Carcinogenesis; Vol 35(6). 2014 Jun.
- 1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer.; Oncotarget; Vol 4(12). 2013 Dec.
- Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D.; The Journal of biological chemistry; Vol 288(1). 2013 Jan 4.
- Deficiency in TR4 nuclear receptor abrogates Gadd45a expression and increases cytotoxicity induced by ionizing radiation.; Cellular & molecular biology letters; Vol 17(2). 2012 Jun.
- A positive feedback signaling loop between ATM and the vitamin D receptor is critical for cancer chemoprevention by vitamin D.; Cancer research; Vol 72(4). 2012 Feb 15.
- Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis.; Reproductive biology and endocrinology : RB&E; Vol 10. 2012.
- Testicular nuclear receptor 4 (TR4) regulates UV light-induced responses via Cockayne syndrome B protein-mediated transcription-coupled DNA repair.; The Journal of biological chemistry; Vol 286(44). 2011 Nov 4.
- Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I.; Molecular endocrinology (Baltimore, Md.); Vol 25(8). 2011 Aug.
- Premature aging with impaired oxidative stress defense in mice lacking TR4.; American journal of physiology. Endocrinology and metabolism; Vol 301(1). 2011 Jul.
- Increased acetylation in the DNA-binding domain of TR4 nuclear receptor by the coregulator ARA55 leads to suppression of TR4 transactivation.; The Journal of biological chemistry; Vol 286(24). 2011 Jun 17.
- Metformin inhibits nuclear receptor TR4-mediated hepatic stearoyl-CoA desaturase 1 gene expression with altered insulin sensitivity.; Diabetes; Vol 60(5). 2011 May.
- Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3.; The American journal of pathology; Vol 178(2). 2011 Feb.
- The roles of testicular nuclear receptor 4 (TR4) in male fertility-priapism and sexual behavior defects in TR4 knockout mice.; Reproductive biology and endocrinology : RB&E; Vol 9. 2011.
- Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.; The Journal of steroid biochemistry and molecular biology; Vol 120(1). 2010 May.
- Activation of TR4 orphan nuclear receptor gene promoter by cAMP/PKA and C/EBP signaling.; Endocrine; Vol 36(2). 2009 Oct.
- TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation.; Proceedings of the National Academy of Sciences of the United States of America; Vol 106(32). 2009 Aug 11.
- Oxidative stress stimulates testicular orphan receptor 4 through forkhead transcription factor forkhead box O3a.; Endocrinology; Vol 149(7). 2008 Jul.
- A new prostate cancer therapeutic approach: combination of androgen ablation with COX-2 inhibitor.; International journal of cancer; Vol 123(1). 2008 Jul 1.
- Protective role of 1 alpha, 25-dihydroxyvitamin D3 against oxidative stress in nonmalignant human prostate epithelial cells.; International journal of cancer; Vol 122(12). 2008 Jun 15.
- Subfertility with defective folliculogenesis in female mice lacking testicular orphan nuclear receptor 4.; Molecular endocrinology (Baltimore, Md.); Vol 22(4). 2008 Apr.
- Loss of TR4 orphan nuclear receptor reduces phosphoenolpyruvate carboxykinase-mediated gluconeogenesis.; Diabetes; Vol 56(12). 2007 Dec.
- Increased expression of corepressors in aggressive androgen-independent prostate cancer cells results in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.; Molecular cancer research : MCR; Vol 5(9). 2007 Sep.
- Loss of testicular orphan receptor 4 impairs normal myelination in mouse forebrain.; Molecular endocrinology (Baltimore, Md.); Vol 21(4). 2007 Apr.
- Docetaxel-induced growth inhibition and apoptosis in androgen independent prostate cancer cells are enhanced by 1alpha,25-dihydroxyvitamin D3.; Cancer letters; Vol 247(1). 2007 Mar 8.
- Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D3 analogs as therapeutic agents for prostate cancer.; The Journal of steroid biochemistry and molecular biology; Vol 103(3-5). 2007 Mar.
- Loss of Testicular Orphan Receptor 4 Impairs Normal Myelination in Mouse Forebrain; Mol.Endocrinol.. 2007 Jan 01.
- Evaluation of C-2-substituted 19-nor-1alpha,25-dihydroxyvitamin D(3) analogs as therapeutic agents for prostate cancer; J.Steroid Biochem.Mol.Biol.. 2007 Jan 01.
- Transactivation of the proximal promoter of human oxytocin gene by TR4 orphan receptor.; Biochemical and biophysical research communications; Vol 351(1). 2006 Dec 8.
- 1alpha, 25-dihydroxyvitamin D3 suppresses interleukin-8-mediated prostate cancer cell angiogenesis.; Carcinogenesis; Vol 27(9). 2006 Sep.
- 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases.; Carcinogenesis; Vol 27(1). 2006 Jan.
- 9-cis-retinoic acid inhibits androgen receptor activity through activation of retinoid X receptor.; Molecular endocrinology (Baltimore, Md.); Vol 19(5). 2005 May.
- Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity.; Endocrine; Vol 26(1). 2005 Feb.
- Modulation of the retinoic acid-induced cell apoptosis and differentiation by the human TR4 orphan nuclear receptor.; Biochemical and biophysical research communications; Vol 323(3). 2004 Oct 22.
- Growth retardation and abnormal maternal behavior in mice lacking testicular orphan nuclear receptor 4.; Proceedings of the National Academy of Sciences of the United States of America; Vol 101(42). 2004 Oct 19.
- A gene expression signature associated with metastatic outcome in human leiomyosarcomas.; Cancer research; Vol 64(20). 2004 Oct 15.
- The role of N-methyl-D-aspartate receptors in neurobehavioral changes induced by toluene exposure during synaptogenesis.; Annals of the New York Academy of Sciences; Vol 1025. 2004 Oct.
- Targeted inactivation of testicular nuclear orphan receptor 4 delays and disrupts late meiotic prophase and subsequent meiotic divisions of spermatogenesis.; Molecular and cellular biology; Vol 24(13). 2004 Jul.